INTRODUCTION
============

Skin, the largest organ of the human body, has an essential function as an inside/outside barrier. It is composed of two main tissue types: the epidermis constantly regenerated from keratinocytes and the dermis, an extracellular matrix (ECM) with fibroblasts providing the major cellular component. The two tissue types are separated by the basement membrane (BM), which also serves as an adherence structure for the epidermis. The basal layer of the epidermis mainly consists of epidermal stem cells and proliferative progenitor cells. The proliferating basal cells generate a suprabasal layer of nondividing cells that, upon further stratification, undergo a sequential program of differentiation, terminating in dead horn squames that are continually shed from the outer surface. To maintain this homeostasis, proliferation and differentiation must be perfectly balanced. Although markers defining the different stages of human epidermal differentiation are already well described, the regulatory mechanisms underlying that process are still poorly understood.

It is widely documented that this regulation not only is an intrinsic trait of the epidermis itself but depends on an active paracrine interaction with its dermal microenvironment, providing growth factors and signals that facilitate epidermal stem cell maintenance, regeneration, and differentiation (Maas-Szabowski *et al.*, [@B28]; Szabowski *et al.*, [@B46]; Boehnke *et al.*, [@B1]). The transforming growth factor-β (TGFβ) is well implicated in this scenario by its dual function as inhibitor of epithelial cell growth and activator of fibroblast proliferation and protein synthesis. Thus TGFβ is involved in controlling the composition of the ECM and the epithelial microenvironment, including the epidermal stem cell niche. Accordingly, it was recently shown that the TGFβ family members not only are important regulators of stem cell renewal and differentiation, but they also contribute to tissue patterning (De Robertis and Kuroda, [@B9]; Watabe and Miyazono, [@B48]).

TGFβ-signals are perceived by cells through heteromeric complexes of two Type I and two Type II TGFβ receptors, both of which are transmembrane serine/threonine kinases. Downstream signaling is mediated by Smad molecules as well as other pathways, such as Erk, c-jun-N-terminal kinase, p38 mitogen-activated protein kinase, and phosphatidylinositol-3′ kinase pathways (for a review, see Moustakas and Heldin, [@B30]). The canonical TGFβ/Smad pathway comprises phosphorylation and thereby activation of Smad2 and Smad3, forming complexes with Smad4 that are translocated into the nucleus to regulate transcription of TGFβ-responsive genes. Signal transduction is antagonized by the endogenous inhibitor Smad7, a target gene of Smad signaling that functions in a negative feedback loop.

TGFβ and its canonical Smad pathway have been studied in a number of mouse models, demonstrating their important role in skin development. Generally, interferences with the Smad pathway resulted in hair follicle phenotypes while the interfollicular epidermis (IFE) remained largely unaffected (Owens *et al.*, [@B33]). In human skin, hair follicles are generally rare, and a multilayered IFE prevails. Thus it remains elusive how abrogation of Smad pathway regulation would interfere with the differentiation process of the IFE in human skin. To better understand TGFβ/Smad regulation in human keratinocytes, many studies were performed in conventional two-dimensional (2D)-monolayer cultures using immortalized human HaCaT skin keratinocytes as an accepted model, which allowed deeper insights into the regulation of TGFβ-dependent Smad signaling and distinct functional consequences in vitro (for a review, see Brown *et al.*, [@B2]). Its impact on tissue organization and proper epidermal differentiation could not be addressed, however, due to the lack of appropriate human three-dimensional (3D) skin models. We recently demonstrated the significance of 3D organotypic cultures (OTCs) for epidermal stem cell growth and differentiation (Stark *et al.*, [@B45], [@B44]; Muffler *et al.*, [@B31]) and used these OTCs here to investigate the role of TGFβ/Smad signaling in the process of human epidermal growth and differentiation.

By interfering with the TGFβ pathway at different nodes and analyzing the resulting effects on tissue formation, we could uncover decisive functions of canonical Smad signaling in the regulation of human epidermal differentiation and provide new major insights into TGFβ/Smad signaling as a key regulator of alternative epithelial differentiation programs.

RESULTS
=======

Two modes to interfere with TGFβ-dependent growth inhibition
------------------------------------------------------------

The central role of the Smad pathway in TGFβ-mediated signaling prompted us to investigate two HaCaT variants genetically engineered to intervene at different points with this pathway: H-S234KD cells transfected with a single RNA interference vector simultaneously targeting Smad2, Smad3, and Smad4 (Jazag *et al.*, [@B22]), and H-Smad7 cells selected for strong and stable expression of the inhibitory Smad7 (Supplemental Figure S1).

When measuring growth kinetics upon TGFβ-treatment (5 ng/ml), the parental HaCaT cells rapidly underwent growth arrest, whereas the genetically engineered cell lines continued to proliferate (Supplemental Figure S2). Interestingly, both cell lines exhibited accelerated growth in the absence of TGFβ, and even upon TGFβ treatment the growth rates did not fall below that of untreated parental HaCaT cells.

Both HaCaT variants show different responses in the canonical Smad pathway
--------------------------------------------------------------------------

To characterize the effects of distinct interferences on TGFβ signaling, we investigated the response profiles of the canonical Smad pathway. As expected, TGFβ caused rapid phosphorylation of Smad2 and Smad3 at the expense of total Smad protein in the TGFβ-sensitive control HaCaT cells. In H-S234KD cells, phosphorylation of Smad2 was minimal, and Smad3 phosphorylation occurred only later ([Figure 1A](#F1){ref-type="fig"}). The Smad3 level being generally low may suggest that TGFβ treatment actually induced de novo expression of Smad3. Indeed, when measuring Smad3 RNA expression, real-time PCR revealed a steady increase in HaCaT cells and a clear increase in H-S234KD cells after 24 h ([Figure 1B](#F1){ref-type="fig"}). In H-Smad7 cells, transient phosphorylation of Smad2 and continuous phosphorylation of Smad3 were induced in response to TGFβ, whereas Smad3 RNA expression remained largely unchanged for up to 72 h ([Figure 1](#F1){ref-type="fig"}, A and B).

![Interference with TGFβ/Smad pathway causes diverse molecular responses. (A) Western blot analyses from untreated and TGFβ-treated lysates from HaCaT, H-S234KD, and H-Smad7 cells were performed to determine the degree of Smad2 and -3 phosphorylation and total nonphosphorylated Smad2 and -3 expression as well as the level of target gene---p15, p21, PAI-1, and CDK4---induction on 6, 24, 48, and 72 h of TGFβ treatment. *Ponceau,* staining for loading control. (B) qRT-PCR analysis of Smad3 RNA expression in HaCaT, H-S234KD, and H-Smad7 cells on 6, 24, 48, and 72 h of TGFβ treatment.](782fig1){#F1}

To be functionally active, the phosphorylated Smad proteins require translocation into the nucleus (Inman *et al.*, [@B20]). Therefore we determined the subcellular localization of Smad2 and Smad3 before and after 90 min of TGFβ treatment ([Figure 2](#F2){ref-type="fig"}). Before TGFβ treatment, all cells showed some cytoplasmic localization of Smad2 and Smad3, although the number of positive cells and the staining intensity varied ([Figure 2](#F2){ref-type="fig"}, A, A′--C, and C′). On TGFβ treatment, nuclear translocation of Smad2 and Smad3 occurred in 100% of the parental HaCaT cells ([Figure 2](#F2){ref-type="fig"}, D and D′) and in ∼25% of the H-S234KD cells ([Figure 2](#F2){ref-type="fig"}, E and E′), suvggesting that this subfraction of cells may express residual amounts of Smads, responsible for the Smad phosphorylation seen in the Western blots (see [Figure 1A](#F1){ref-type="fig"}). In cultures of Smad7 cells, all of the nuclei were positively stained, albeit at a low level ([Figure 2](#F2){ref-type="fig"}, F and F′).

![Nuclear translocation of Smad2/3 occurs in HaCaT cells and all variants upon TGFβ treatment. Immunofluorescence detection of Smad2 and -3 in HaCaT (A/A′ and D/D′), H-S234KD (B/B′ and E/E′), and H-Smad7 cells (C/C′ and F/F′) before and after a 90-min treatment with TGFβ (5 ng/ml). Nuclei, Hoechst counterstain. Bar = 50 μm.](782fig2){#F2}

As these findings argued for some Smad pathway activation also in the HaCaT variants, we analyzed the expression patterns of known target genes (i.e., cyclin-dependent kinase inhibitors p15*^INK4B^* \[hereafter p15\], p21*^WAF1/Cip1^* \[hereafter p21\], and plasminogen activator inhibitor type 1 \[PAI-1\]) (Dennler *et al.*, [@B10]; Song *et al.*, [@B43]; Hua *et al.*, [@B18]; Datta *et al.*, [@B8]; Providence *et al.*, [@B36]) ([Figure 1A](#F1){ref-type="fig"}). While in control HaCaT cells, the level of all three proteins was strongly induced within 6 h of TGFβ treatment, H-S234KD cells showed a temporary induction of p21 and PAI at 6 h and a continuous increase of p15 expression. Otherwise, H-Smad7 cells showed an induction of p21 and, to a lesser extent, of PAI-1, whereas p15 remained suppressed. Thus neither of the two HaCaT variants became fully unresponsive to TGFβ, but the canonical Smad pathway was clearly impaired in H-S234KD and H-Smad7 cells, although with different downstream consequences.

Halder *et al.* (Halder *et al.*, [@B15]) proposed a down-regulation of the cell-cycle activator CDK4 in response to TGFβ under contribution of Smad proteins. Indeed, CDK4 gene expression was completely inhibited by TGFβ in the parental HaCaT cells and remained unaltered in both variants ([Figure 1A](#F1){ref-type="fig"}). In contrast, cyclin D1, the regulatory subunit of CDK4 (Hunter and Pines, [@B19]), even increased upon TGFβ treatment in the parental HaCaT cells as well as in the HaCaT variants (Supplemental Figure S3 and unpublished data), suggesting that CDK4, but not cyclin D1, is regulated in the TGFβ-dependent scenario.

Interference with TGFβ/Smad signaling impairs tissue homeostasis and overcomes TGFβ-mediated growth arrest also in the in vivo--like OTCs
-----------------------------------------------------------------------------------------------------------------------------------------

In skin, epidermal proliferation and morphogenesis are regulated by the mutual interaction of the epidermal keratinocytes with the dermal fibroblasts and/or the factors derived from these cells (Maas-Szabowski *et al.*, [@B27]; Boehnke *et al.*, [@B1]). In OTCs of human keratinocytes, this interplay is well recapitulated, and TGFβ can exert its opposed effect on the dermal fibroblasts, which, in contrast to keratinocytes, are stimulated to proliferate and to synthesize matrix proteins (for a review, see Brown *et al.*, [@B2]). To evaluate the impact of Smad-pathway interference in this in vivo--like environment, we established OTCs with the different HaCaT variants. Without exogenous TGFβ, parental HaCaT cells formed a stratified, well-differentiated, epidermis-like epithelium with few proliferating cells in the basal compartment ([Figure 3A](#F3){ref-type="fig"}). On TGFβ treatment, HaCaT cells were significantly growth inhibited despite the fact that the number of fibroblasts was significantly increased ([Figure 3A′](#F3){ref-type="fig"}), confirming their sensitivity to TGFβ also in the "in vivo" situation. Different from the parental cells, the HaCaT variants formed stratified epithelia that were altered in cell morphology and histology. Moreover, they showed increased proliferation in the absence of exogenous TGFβ ([Figure 3](#F3){ref-type="fig"}, B and C). Most notably, proliferation was no longer restricted to the basal layer, indicating that impaired Smad signaling remarkably affected tissue homeostasis. Exposure to TGFβ did not result in reduced epithelial proliferation ([Figure 3](#F3){ref-type="fig"}, B′ and C′), confirming that, also under these in vivo--like conditions, TGFβ-dependent growth inhibition was largely diminished.

![In OTC proliferation control by TGFβ1 is abrogated in the HaCaT variants. Immunofluorescence staining of 3-wk-old OTCs of HaCaT (A), HS234KD (B), and H-Smad7 (C) cells for proliferation (Ki67 in red) and collagen Type IV (col IV in green) to mark the BM separating the epithelium from the dermal compartment. (A--C), untreated cultures; (A′-C′), cultures treated with TGFβ. Note the increased number and the abnormal suprabasal distribution of Ki67-positive cells in the three variants. Nuclei, Hoechst counterstain.](782fig3){#F3}

Abrogation of TGFβ-dependent growth inhibition does not impair sensitivity to other growth-stimulating factors
--------------------------------------------------------------------------------------------------------------

Different from monolayer cultures, with TGFβ treatment still causing some growth reduction (see Supplemental Figure S2), H-Smad7 cells responded to TGFβ with epithelial hyperplasia when grown in OTCs (see [Figure 3C′](#F3){ref-type="fig"}). To determine whether this response was based on inherent properties or was a result of extrinsic stimulation (i.e., paracrine interaction through growth factors provided by the TGFβ-stimulated dermal fibroblasts), H-Smad7 cells were first grown in the absence of fibroblasts. The developing epithelium consisted of only a few cell layers ([Figure 4A](#F4){ref-type="fig"}), demonstrating that similar to normal keratinocytes and HaCaT cells (Boehnke *et al.*, [@B1], and unpublished data), these cells still depended on the paracrine stimulation by fibroblast-derived factors for steady proliferation and formation of a stratified epithelium. With fibroblasts present, a multilayered epithelium was formed ([Figure 4B](#F4){ref-type="fig"}), which, upon TGFβ treatment, became severely hyperplastic ([Figure 4C](#F4){ref-type="fig"}).

![(A--F) Dependence on dermal fibroblasts and their growth factors is unaltered. Histological sections of H-Smad7 cells were grown in OTCs for 3 wk without fibroblasts (- fib) (A), with fibroblasts (+ fib) in the dermal equivalent (B), with fibroblasts in the presence of TGFβ (+ fib + TGFβ) (C), and on treatment with a neutralizing antibody against the EGFR (+ fib + TGFβ + αEGRF) (D), in the presence of TGFβ and a neutralizing antibody against KGF (+ fib + TGFβ + αKGF) (E), as well as addition of the two neutralizing antibodies against KGF and EGFR (+fib + TGFβ + αKGF + αEGRF) (F). Histological sections of HaCaT (G--I) and H-Smad7 epithelia (J--L) grown in OTCs for 16 d and treated with TGFβ (G and J), TGFβ plus a neutralizing antibody against TGFβ (αTGFβ, H and K), and the neutralizing antibody against TGFβ only (I and L). Bar = 100 μm.](782fig4){#F4}

To further determine the role of TGFβ in epithelial hyperplasia, we blocked its action in HaCaT and H-Smad7 OTCs by the addition of a neutralizing antibody ([Figure 4](#F4){ref-type="fig"}, G--L). As expected, in HaCaT OTCs the TGFβ-dependent growth inhibitory effect was completely abolished, and the cells formed a well-stratified and differentiated epidermis-like epithelium ([Figure 4](#F4){ref-type="fig"}, G and H), clearly demonstrating the efficacy of the neutralizing antibody. Also, without exogenous TGFβ, the addition of the neutralizing antibody allowed for the formation of a similar well-stratified and differentiated epithelium, suggesting that endogenous TGFβ was negligible for epidermal tissue morphogenesis ([Figure 4I](#F4){ref-type="fig"}). Furthermore proliferation remained restricted to the basal layer (unpublished data). In H-Smad7 cultures, in contrast, the TGFβ-neutralizing antibody prevented hyperplasia ([Figure 4](#F4){ref-type="fig"}, J and K), and the thickness of the epithelium was similar to that of H-Smad7 control cultures or cultures treated only with the neutralizing antibody ([Figure 4L](#F4){ref-type="fig"} and unpublished data).

As EGF and the mesenchyme-derived keratinocyte growth factor (KGF) are major keratinocyte mitogens (Shirakata, [@B41]), we applied inhibitory antibodies against EGF receptor (EGFR) (in the presence of TGFβ) to H-Smad7 cultures, and hyperplasia was consequently inhibited ([Figure 4D](#F4){ref-type="fig"}). Furthermore neutralizing antibodies against KGF had an even stronger effect ([Figure 4E](#F4){ref-type="fig"}) and, finally, a simultaneous inhibition of KGF and EGFR reduced stratification to the level seen in the absence of fibroblasts ([Figure 4F](#F4){ref-type="fig"}). The addition of an isotypic control antibody against an irrelevant epitope (pox virus protein) had no effect on the growth of the H-Smad7 cells (unpublished data). Together these results confirmed the important role of TGFβ in inducing EGF and KGF as crucial paracrine growth regulators for epithelial cell hyperplasia and illustrate the importance of TGFβ signaling as a counterbalancing negative control to achieve tissue homeostasis.

Attenuated TGFβ/Smad signaling entails altered epidermal morphogenesis and differentiation in OTCs
--------------------------------------------------------------------------------------------------

Interference with TGFβ/Smad pathway regulation led to modulated proliferation and distinct alterations in tissue morphology. Only the parental HaCaT cells developed a regular, well-organized parakeratotic epidermis-like epithelium ([Figure 5A](#F5){ref-type="fig"}). H-S234KD and H-Smad7 epithelia had largely lost their epidermal architecture. They were composed of rather uniform small cells and contained either sporadically (H-S234KD epithelia) or frequently (H-Smad7 epithelia) balloon-like cavities ([Figure 5](#F5){ref-type="fig"}, B and C). Both number and size of these cavities increased with time, suggesting that they reflected an inherent property of this alternative differentiation program.

![Abrogation of epidermal tissue morphology by impaired TGFβ/Smad signaling. Histological sections of 3-wk-old OTCs from HaCaT cells and the transgenic HaCaT variants untreated (A--C) and treated with TGFβ (A′--C′). (A) The parental HaCaT cells show a typical epidermis-like epithelium with a parakeratotic *stratum corneum*. (B) The H-S234KD epithelia are composed of uniform small cells regularly forming cavities in the upper part of the epithelium. (C) H-Smad7 cells form a similar non-epidermal-type epithelium, however, with an increased number of cavities. Upon TGFβ treatment, (A′) HaCaT growth is restricted to only one to two cell layers of flat cells. (B′) The morphology of H-S234KD is largely unchanged except that the number of cavities is reduced. (C′) H-Smad7 cells have formed a non-epidermal-like hyperplastic epithelium with numerous cavities. Bar = 100 μm.](782fig5){#F5}

On TGFβ treatment, which inhibited proliferation of the HaCaT cells as evident by reducing stratification to one to two layers of flat cells ([Figure 5A′](#F5){ref-type="fig"}), epithelia of the two variants with impaired Smad signaling, the H-S234KD and H-Smad7-cells, stably maintained their non-epidermal phenotype as obvious in histology ([Figure 5](#F5){ref-type="fig"}, B′ and C′).

To define the molecular basis of the changes, we first examined the expression of well-known protein markers for epithelial differentiation stages, including the intermediate filament keratin K5, the desmosomal components desmoplakin and desmoglein (Dsg)3, and the adherence junction molecule, E-cadherin, all of them orderly expressed and distributed in HaCaT epithelia (Supplemental Figure S4, A, D, G, and J). Also, in H-S234KD, epithelia expression and localization were largely unaltered. Otherwise, in H-Smad7 epithelia, these proteins were expressed at reduced levels and with abnormal distributions (Supplemental Figure S4, B, E, H, K and C, F, I, L). In accordance with disturbed tissue homeostasis (i.e., proliferation throughout the epithelium), the β~1~ integrins as cell-matrix adhesion molecules and the hemidesmosomal component α~6~β~4~ integrin, normally restricted to the basal cells (see HaCaT epithelia, Supplemental Figure S4, M and P), were found throughout the entire epithelium in H-S234KD and H-Smad7 OTCs (Supplemental Figure S4, N, Q, and O, R). Vimentin, the typical intermediate filament protein of mesenchymal cells, was restricted to the fibroblasts of the dermal equivalents (Supplemental Figure S4, S--U). These findings provide evidence for the strictly maintained epithelial nature of the modified HaCaT cells without any sign of epithelial--mesenchymal transition (EMT) as a result of Smad pathway abrogation (for a review, see Heldin *et al.*, [@B17]).

With the onset of differentiation, HaCaT keratinocytes expressed the keratins K1 and K10 ([Figure 6A](#F6){ref-type="fig"}), the cornified envelope protein involucrin (unpublished data), the epidermis-specific transglutaminase-1 ([Figure 6D](#F6){ref-type="fig"}), and Dsg1 ([Figure 6G](#F6){ref-type="fig"}), the major desmosomal cadherin in the suprabasal layers of the epidermis (Green and Simpson, [@B14]). This regular pattern was also found in H-S234KD epithelia ([Figure 6](#F6){ref-type="fig"}, B and E) with the exception of Dsg1, which was strongly reduced ([Figure 6H](#F6){ref-type="fig"}). H-Smad7 cells, in contrast, expressed little, if any, of the examined markers ([Figure 6](#F6){ref-type="fig"}, C, F, and I). Although HaCaT epithelia realized advanced terminal epidermal differentiation as assessed by the expression of filaggrin, loricrin, keratin K2 (formerly K2e), and Dsg4 ([Figure 6](#F6){ref-type="fig"}, J, M, and P, and unpublished data), these markers were largely absent in both variants ([Figure 6](#F6){ref-type="fig"}, K, N, Q and L, O, R).

![Alterations in epidermal differentiation on interference with TGFβ/Smad signaling. Immunofluorescence detection demonstrates a normal distribution of the epidermal differentiation markers keratin K1 and K10, transglutaminase 1, and Dsg1 in HaCaT (A, D, G). In H-S234KD epithelia K1/10 (B) and transglutaminase 1 (E) are normally expressed whereas Dsg1 is largely absent (H). In H-Smad7 epithelia, K1/10 (C) and transglutaminase 1 (F) are only faintly expressed or are lacking (Dsg1; I). The "late" differentiation markers loricrin, keratin K2, and Dsg4 (all in red) are restricted to the HaCaT epithelium (J, M, P), while being absent in the epithelia of H-S234KD (K, N, Q), and H-Smad7 cells (L, O, R). In (A---F) and (J-O), collagen Type IV (col IV) counterstaining is used to demarcate the BM separating the epithelium from the dermal equivalent, and the entire dermal matrix was stained with antisera against fibronectin (G--I) and collagen Type I (P--R). Nuclei, Hoechst counterstain. Bar = 100 μm.](782fig6){#F6}

Impaired TGFβ/Smad signaling in HaCaT keratinocytes induces an alternative differentiation program
--------------------------------------------------------------------------------------------------

The distinct and reproducible phenotype of the H-S234KD and H-Smad7 epithelia not only argued for a block within the epidermal differentiation program, but for a switch to an alternative differentiation route. As cornification was missing, a shift to a "mucous" noncornified squamous epithelium was most likely. Consistent with this hypothesis, the keratins K4 and K13, typical for differentiated layers of squamous epithelia (for a review, see Moll *et al.*, [@B29]) ([Figure 7](#F7){ref-type="fig"}, A and D), were strongly increased and, as in those epithelia, extended throughout the suprabasal strata of both variants ([Figure 7](#F7){ref-type="fig"}, B, E and C, F). Furthermore the simple-epithelial-type keratins---K7, K8, K18, and K19---expressed during embryonic development of the epidermis and characteristic of nonstratified (e.g., intestinal) epithelia, were prominent throughout the epithelium in all HaCaT variants ([Figure 7](#F7){ref-type="fig"}, G--L and unpublished data), arguing for a complex shift in the differentiation program.

![Induction of non-epidermal differentiation markers by impaired TGFβ/Smad signaling. Immunofluorescence detection in 3-wk-old OTCs from HaCaT cells and the two variants, H-S234KD and H-Smad7 cells, of the mucosal keratins K4 (A--C) and K13 (D--F), the "simple-type" intestinal keratins K7 (G--I) and K19 (J--L), and the tight junction protein cingulin (M--O, inset in M showing cingulin expression in human sweat gland) and Dsg2 (P--R, inset in P showing Dsg2 expression in human sweat gland). The marker proteins are shown in red and nuclei in blue. The BM is depicted by collagen IV staining (col IV in green, in A--F) and the fibroblast in the dermal equivalent with vimentin in (M--O). In (G--I) and (P--R) the BM is demarcated by dashed lines. Nuclei, Hoechst counterstain. Bars = 10 μm (insets in M and P), 100 μm (all other images).](782fig7){#F7}

To further characterize this particular differentiation program, we tested for cellular tight junctions that are typical for epithelia with pronounced barrier function and are located in upper living cells of the *stratum granulosum* of the epidermis as well as in glandular epithelia (Langbein *et al.*, [@B23], [@B24], and references therein). Both of the typical tight junction proteins, occludin and cingulin, appeared at the margins of the *granulosum*-like cells in parental HaCaT epithelia ([Figure 7M](#F7){ref-type="fig"} and unpublished data). In H-S234KD and H-Smad7 epithelia, these proteins could also be attributed to the lining of the cavities, strongly resembling glandular structures ([Figure 7](#F7){ref-type="fig"}, M inset, N, and O, and unpublished data). A gland-like differentiation was further supported by the expression of Dsg2, which is predominantly found in sweat gland acini of the skin ([Figure 7](#F7){ref-type="fig"}, P inset, Q, and R, and Green and Simpson, [@B14]). A differentiation typical for sweat gland ductal epithelium, as defined by keratin 77 (formerly K1b) expression, in contrast, could be excluded (unpublished data). Using three different histochemical staining techniques---Periodic acid--Schiff (PAS), mucicarmine, and Alcian blue---the cavities in H-S234KD and H-Smad7 epithelia were identified as mucin-containing structures ([Figure 8](#F8){ref-type="fig"}, A--D, and unpublished data). The biosynthesis of mucin could be confirmed by reverse transcription (RT)-PCR analysis detecting the expression of different mucins, such as mucins 4 and 13, but also of enzymes required for mucin synthesis and modification, such as glucosaminyl (N-acetyl) transferase 3, mucin type (Gcnt3) (Li *et al.*, [@B26]). The expression of mucin 13 and Gcnt3 were less prominent in conventional monolayer cultures of H-S234KD and H-Smad7 cells, but intensified in OTCs ([Figure 8E](#F8){ref-type="fig"}). Obviously, this alternative differentiation program required the tissue context for its optimal development. Furthermore the phenotypic differences between HaCaT cells and the two variants with impaired Smad signaling became even more pronounced in long-term OTCs (\>8 wk). Whereas HaCaT cells regenerated an orthokeratinized epidermis, the epithelia of H-S234KD and H-Smad7 cells retained their alternative phenotype. Furthermore due to the high cellular turnover in H-Smad7 OTCs, accompanied by a steady rupturing of the cavities, increased secretion of mucus, as well as shedding of cellular material, the epithelial thickness became reduced and in 10-wk-old culture closely resembled thin glandular epithelia ([Figure 8](#F8){ref-type="fig"}, F--H).

![Mucin-containing cavities in H-Smad7 epithelia. Epithelia formed by HaCaT (A and C) and H-Smad7 cells (B and D) were stained by PAS and mucicarmin histochemistry. Note the red staining of the cavities, demonstrating mucin content, in H-Smad7 epithelia, whereas individual holes also found in HaCaT epithelia remain unstained. (E) mRNA expression of HaCaT, H-Smad7, and H-S234KD epithelia as well as H-S234KD cells from conventional cultures for mucins 4 and 13 and the Gcnt3 involved in mucin biosynthesis. *GAPDH*, loading control. (F--H) Long-term OTCs of HaCaT and H-Smad7 cells. Whereas HaCaT cells form an orthokeratinized epidermis (F, 10-wk-old epithelium), H-Smad7 cells go through a phase of hyperplasia (G, 6-wk-old epithelium) and continuous release of the cavities, leading to an extensive mucous layer on top of a thin intestine-like epithelium (H, 10-wk-old epithelium).](782fig8){#F8}

Loss of terminal epidermal differentiation correlates with loss of Krueppel-like factor 4
-----------------------------------------------------------------------------------------

Functional impairment of the Smad pathway not only affected expression of single differentiation genes but blocked the entire process of epidermal differentiation. This finding suggests that this pathway plays a crucial role in the regulation of epidermal differentiation. Additional factors reported to be prerequisite for keratinocyte differentiation are inhibitor of nuclear factor kappa-B kinase subunit α (IKKα) and the transcription factor Krueppel-like factor 4 (Klf4). IKKα was recently shown to be an important coregulator of a Smad4-independent TGFβ--Smad2/3 signaling pathway that controls keratinocyte differentiation (Descargues *et al.*, [@B11]). We found that IKKα was equally expressed both in the epithelia of the parental HaCaT cells and in the two genetic variants ([Figure 9](#F9){ref-type="fig"}), suggesting that regulation via IKKα was not the predominant regulatory event underlying epidermal differentiation and that IKKα was not regulated in a Smad pathway--dependent manner.

![Involvement of Klf4 but not IKKα in the regulation of epidermal and alternative differentiation programs. RT-PCR analysis was performed from mRNA isolated from epithelia of parental HaCaT cells, two HaCaT variants, and H-S234KD cells treated with TGFβ. All epithelia were tested for IKKα and Klf4 expression. *GAPDH*, loading control.](782fig9){#F9}

As well, Klf4 has previously been shown to regulate the expression of a group of differentiation-specific epidermal keratins (Chen *et al.*, [@B6]) and to play an important role in controlling barrier function (Patel *et al.*, [@B34]). We found high Klf4 mRNA expression for the epidermal differentiation phenotype of the parental HaCaT cells whereas expression was strongly reduced concomitantly with the alternative differentiation phenotype in the epithelia of the H-234KD and H-Smad7 cells ([Figure 9](#F9){ref-type="fig"}).

Smad pathway abrogation is causal for switching the epithelial differentiation phenotype
----------------------------------------------------------------------------------------

Despite the fact that some Smad pathway activation still occurred in both H-S234KD and H-Smad7 cells, the alternative differentiation phenotype was unaffected by treatment with TGFβ (see [Figure 5](#F5){ref-type="fig"}, B′ and C′). Furthermore Klf4, the crucial factor required for terminal epidermal differentiation, remained suppressed ([Figure 9](#F9){ref-type="fig"} and unpublished data). Therefore we asked whether reduction of the Smad7 level in H-Smad7 cells would allow for reversion to epidermal differentiation. To accomplish sufficient and long-lasting reduction, we treated H-Smad7 OTCs with control and Smad7 antisense oligonucleotides. The application of control oligonucleotides neither affected Smad7 expression nor altered the differentiation profile (Supplemental Figure S5A and [Figure 10](#F10){ref-type="fig"}, A--D). Incubation with Smad7 antisense oligonucleotides, however, caused a significant reduction of Smad7 RNA expression (Supplemental Figure S5B). Concomitantly, markers characteristic for the alternative differentiation (e.g., keratin K7) ([Figure 10A′](#F10){ref-type="fig"}), were strongly down-regulated, whereas the epidermal differentiation markers, shown for involucrin ([Figure 10B′](#F10){ref-type="fig"}), became dominant. Even terminal differentiation markers such as filaggrin were reexpressed, although localized in a scattered pattern ([Figure 10C′](#F10){ref-type="fig"}). Along with decelerated proliferation, tissue homeostasis normalized, as suggested from the distribution of the α~6~ and β~1~ integrin chains, which became restricted to the basal compartment of the epithelium ([Figure 10D′](#F10){ref-type="fig"} and unpublished data). These results could be reproduced with a second set of Smad7 antisense oligonucleotides as well as with a different clone of H-Smad7 cells (unpublished data), thus confirming their general validity.

![Extensive reversion of phenotypic abnormalities by counteraction of TGFβ signaling blockade. Immunofluorescence detection of 4-wk-old OTCs from Smad7 cells grown in the presence of either unrelated oligonucleotides (control, A--D) or Smad7-specific antisense oligonucleotides (antisense, A′--D′). The intestinal keratin K7, which is strongly expressed in the controls (A), is largely absent in oligo-treated cultures (A′). Inversely, the epidermal differentiation marker involucrin largely absent in the control (B) is clearly expressed (B′). Even the "late" epidermal differentiation marker filaggrin, absent in the control (C), is reexpressed in the Smad7-oligonucleotide--treated epithelium (C′). Integrin α~6~ expressed throughout the epithelium in the control (D) is largely restricted to the basal layer (D′), indicating phenotypic normalization on smad7 antisense oligonucleotide treatment. All of the previously mentioned proteins are shown in red. Nuclei are counterstained with DAPI (blue), and collagen Type I (col I: B, B′) and collagen Type IV (col IV: C, C′), both in green, are marking the dermal equivalent and BM, respectively. The BM in A and A′ is demarcated by dashed lines. Nuclei, Hoechst counterstain. Bar = 100 μm.](782fig10){#F10}

Collectively these observations strongly argue for the absolute necessity of an intact and active Smad pathway for the process of regular epidermal differentiation and for its role as a regulatory switch between different epithelial differentiation programs.

DISCUSSION
==========

To study the role of TGFβ-Smad signaling in the growth and differentiation of human skin keratinocytes, we engineered HaCaT variants, H-S234KD and H-Smad7 cells, that showed impaired Smad signaling as verified by decreased Smad phosphorylation, nuclear translocation, and altered target gene expression profiles. As expected, these cells exhibited a distinct abrogation of the well-known TGFβ-dependent growth inhibition in conventional cultures and proved to be excellent tools to unravel how the Smad pathway contributes to growth and differentiation also under in vivo--like conditions (i.e., when propagated in OTCs). From these studies two major findings emerged. First, epidermal tissue homeostasis, closely linked to the epidermal differentiation process, required active TGFβ/Smad signaling. Second, active Smad signaling was essential for terminal epidermal differentiation. Abrogation of the Smad signaling pathway not only blocked the epidermal differentiation process but induced a switch to a highly complex alternative differentiation program, suggesting that TGFβ/Smad signaling was responsible for programming different epithelial differentiation routes.

Smad signaling regulates tissue homeostasis
-------------------------------------------

So far, studies that address the role of TGFβ/Smad signaling in tissue regulation are restricted to mice. These studies showed that knockdown of Smad2 and Smad3 in the epidermis did not result in any obvious skin phenotype; however, Smad4 deletion resulted in hair follicle collapse. Whereas the triple knockdown of Smad2, -3, and -4 in keratinocytes was not yet reported, Smad7 overexpression showed the most distinct effects (reviewed in Owens *et al.*, [@B33]). These mice exhibited multiple developmental defects in the stratified epithelia, and, when using an inducible system for overexpressing Smad7 at different stages of development in the epithelial cells, Han and coworkers demonstrated a significant delay in embryonic hair follicle development and complete blockade of hair follicle differentiation. Actually, sebaceous gland development was significantly accelerated, and epidermal differentiation was perturbed (Han *et al.*, [@B16]). Furthermore these mice exhibited aberrant hair follicle cycling (Han *et al.*, [@B16]), suggesting a major disturbance in hair follicle homeostasis. In agreement with this finding, when performing H-Smad7 OTCs, the epithelia were not able to establish a stage of tissue homeostasis. Different from the epidermis of normal keratinocytes or HaCaT epithelia, where proliferation is restricted to the basal cell compartment and the integrin distribution is well organized, the Smad7-overexpressing H-Smad7 cells exhibited increased proliferation throughout all epithelial layers and, accordingly, an integrin profile similarly extending throughout the epithelium. As disturbance in tissue homeostasis remained unaffected by TGFβ treatment or long-term growth (\>10 wk) in OTCs, and was similarly characteristic for the H-S234KD cells, these data strongly suggest that abrogation of Smad signaling was crucial for this abnormal growth behavior.

Different from the situation in monolayer cultures where TGFβ still caused some reduction in proliferation, the level of keratinocyte proliferation even increased upon TGFβ treatment when the HaCaT variants were cultivated in OTCs. In this tissue context, similar to that in skin, growth factors are provided by the dermal fibroblasts that, in a paracrine regulation, are responsible for epidermal growth and differentiation (Contard *et al.*, [@B7]; Fusenig, [@B13]; Smola *et al.*, [@B42]; Szabowski *et al.*, [@B46]; El Ghalbzouri *et al.*, [@B12]). Accordingly, the severe hyperplasia of H-Smad7 epithelia, occurring upon TGFβ treatment in OTCs, could be ascribed to a still functional response to the growth-promoting factors provided by the dermal fibroblasts. Blocking the actions of EGFR or KGF caused reduction of hyperplastic growth, and the combined blockade of both confirmed that H-Smad7 cells depended on the growth-promoting action of the "dermis"-derived growth factors in the same way as the parental HaCaT cells or normal keratinocytes (Boehnke *et al.*, [@B1]). Thus abrogating the negative growth regulation by TGFβ resulted in an unrestricted response to keratinocyte mitogens and hyperplasia, further arguing for TGFβ/Smad signaling as being the crucial regulator counterbalancing growth promotion during epidermal tissue regeneration.

Active Smad signaling is essential for terminal epidermal differentiation
-------------------------------------------------------------------------

Most importantly, impaired TGFβ/Smad signaling also caused a distinct differentiation phenotype. EMT, as a consequence of TGFβ action (for a review, see Heldin *et al.*, [@B17]) was not observed. The epithelial phenotype, evidenced by the expression of a large set of epithelial markers including E-cadherin and the lack of expression of the mesenchymal marker vimentin, was maintained in both variants. Thus EMT may not be a general response of HaCaT cells to TGFβ, but may require additional alterations in epithelial cells that occur during the process of tumorigenic transformation (e.g., H-ras activation), as recently proposed (Schafer and Werner, [@B38]). Consistently, none of the variants formed tumors when injected subcutaneously into nude mice (Boukamp, unpublished data). Instead, in OTCs, loss of epidermal differentiation was accompanied by a considerable decline in the expression of Klf4. This transcription factor has been shown to be essential for the formation of the epidermal barrier (Patel *et al.*, [@B34]) by regulating genes such as keratin K1, involucrin, or repetin and thereby contributing to a balanced cornified envelope assembly (Segre *et al.*, [@B40]). Actually, a 14-fold decline of Klf4 was first identified by RNA expression array analysis in conventional cultures of H-S234KD and H-Smad7 cells (unpublished data), and this strong reduction was confirmed in epithelia of both variants ([Figure 9](#F9){ref-type="fig"}). In contrast, a third HaCaT variant being abrogated in TGFβ-dependent growth inhibition, but still exhibiting a fully functional TGFβ/Smad pathway response, maintained its epidermal phenotype and kept up high Klf4 expression in conventional cultures similar to the parental HaCaT cells (unpublished data). Thus Klf4 expression precedes the actual differentiation process only in cells competent for epidermal differentiation. This finding, in turn, suggests that loss of Klf4 expression in the variants is not a consequence of attenuated terminal epidermal differentiation, but rather may be a direct effect of Smad-mediated transcriptional control.

Loss of the epidermal differentiation potential was accompanied by the occurrence of a distinct alternative epithelial phenotype. Both variants expressed a marker profile that was best defined as mucous/intestinal-type epithelial differentiation. This stable phenotypic switch could only be reverted when treating the H-Smad7 epithelia with Smad7 antisense oligonucleotides and thereby reducing the level of Smad7. This treatment resulted in reexpression of epidermal and suppression of mucous/intestinal differentiation markers substantiating that the phenotypic switch indeed depended on active TGFβ/Smad signaling.

The two genetic variants exhibited a similar, although not identical, differentiation phenotype. Both displayed induction of a mucous/intestinal-type differentiation, however, the H-S234KD epithelia still coexpressed the basic epidermal differentiation set ("early" epidermal differentiation markers), whereas overexpression of Smad7 seemed to cause a more complete switch by blocking the entire epidermal differentiation program. Unfortunately, a mouse correlate for the H-S234KD cells was not yet described. In the Smad7 transgenic mouse model, however, hair follicle morphogenesis was delayed or even abrogated, whereas sebaceous gland development was significantly accelerated and reinforced (Han *et al.*, [@B16]). In light of our findings that Smad7 overexpression in human HaCaT keratinocytes resulted in a switch from a cornified squamous (epidermal) to a mucous/intestinal-type differentiation with markers characteristic for glandular-like differentiation, it is tempting to speculate that high levels of Smad7 in mouse skin actually promoted sebaceous differentiation at the expense of hair follicle differentiation.

Concerning the mechanisms of this differentiation programming, it was shown that Smad7 negatively interacts with β-catenin by degrading it and thereby antagonizing Wnt/β-catenin signaling (Han *et al.*, [@B16]). As the Wnt-pathway is a substantial activator of hair follicle morphogenesis (Ito *et al.*, [@B21]), the observed severe disturbance of hair follicle morphology in mice with Smad7-overexpression in skin was expected. For the IFE, the role of Wnt signaling is still elusive (Watt and Collins, [@B49]). Nevertheless, two of our observations indicate a potential role for Smad7 in degrading β-catenin: In 2D cultures of H-Smad7 cells β-catenin became reduced upon TGFβ treatment (Supplemental Figure S3), and immunostaining of H-Smad7 epithelia revealed a less regular membrane localization of the E-cadherin/β-catenin complex compared with that in epithelia of parental HaCaT cells (Supplemental Figure S4 and unpublished data). In IFE, however, a causal relationship between reduced Wnt/β-catenin signaling and loss of epidermal differentiation is unlikely, which is also suggested by studies specifically addressing the role of Wnt pathway activation in epidermal differentiation (Wischermann, Stark, and Boukamp, unpublished data) and further supported by the fact that a similar nonepidermal phenotype developed through abrogation of Smad2, -3, and -4. Our data suggest that active TGFβ/Smad signaling is indispensable for epidermal differentiation. Furthermore, because impeding it induces a complex shift to a mucous/intestinal-like differentiation with all specific features including mucous formation, TGFβ/Smad signaling appears to be the crucial determinant of the terminal differentiation program in the IFE.

TGFβ is interconnected with multiple regulatory effectors in an intricate network (Moustakas and Heldin, [@B30]). Accordingly, it was suggested that TGFβ modulates differentiation through the regulation of Id proteins by interfering with *prodifferentiation* basic helix-loop-helix transcription factors (Tang *et al.*, [@B47]). HaCaT keratinocytes overexpressing Id 1 showed hyperproliferation in OTCs, although still restricted to the basal layer, and an abnormal (patchy) distribution of the "late" epidermal differentiation markers (Rotzer *et al.*, [@B37]). This underlines the contribution of Id-1 in differentiation control. The phenotypic differences presented here, however, question a major role of Id-1 in the TGFβ-dependent scenario. In contrast, overexpression of cyclin D1 caused a comparable abnormal distribution of proliferation throughout the entire epithelium (Burnworth *et al.*, [@B3]). Notably, cyclin D1 expression was not altered by Smad pathway interference, as it increased upon TGFβ treatment in control HaCaT cells as well as H-Smad7 cells, arguing against a Smad pathway--dependent mechanism as the only initiator of disturbed homoeostasis and anomalous suprabasal proliferation. Consequently, an additional nonSmad pathway--dependent regulation may elicit this particular proliferation phenotype.

In summary, we used HaCaT cells that were modulated in their TGFβ signaling as surrogates of human interfollicular epidermal keratinocytes in an in vivo--like experimental approach (OTC), and our results contribute toward unraveling further the multiple roles of TGFβ in epidermal growth and differentiation. We show for the first time that both the observed TGFβ-dependent growth suppression and "in vivo"--dependent human epidermal tissue homeostasis are regulated in a spatiotemporal manner by the interplay of Smad-dependent and independent pathway controls. In contrast, Smad signaling is indispensable for terminal epidermal differentiation and is central in the decision between alternative epithelial differentiation programs.

MATERIALS AND METHODS
=====================

Cell cultures and transfection
------------------------------

HaCaT cells and H-S234KD cells expressing small interfering RNA against Smad2, -3, and -4 (Jazag *et al.*, [@B22]) were maintained in DMEM (Lonza, formerly Cambrex, Verviers, Belgium), supplemented with 5% fetal calf serum (FCS) (Biochrom, Berlin, Germany). H-Smad7 cells were generated by transfecting HaCaT cells with a pcDNA3 expression vector containing the murine Smad7 cDNA with a Flag-tag at its N terminus (Nakao *et al.*, [@B32]). Transfections were performed using Effectene Transfection Reagent (Qiagen, Hilden, Germany) and transfectants selected in DMEM/5% FCS containing G418 at 800 μg/ml. Two clones overexpressing Flag-Smad7 were selected for further analysis, one constitutively expressing high amounts of Flag-Smad7 and the other showing increased amounts upon TGFβ1 treatment (Supplemental Figure S1).

OTCs, using Type I collagen gels with integrated fibroblast as dermal equivalents, were performed as described (Schoop *et al.*, [@B39]). HaCaT cells or the transgenic variants were seeded on top of the collagen gels and, after 24 h of submersed cultivation, the cultures were air lifted. Medium was changed every second day. Where indicated, 5 ng/ml were added to the culture medium with the air lift, and medium including TGFβ1 was renewed every second day. Long-term OTCs were performed as described (Stark *et al.*, [@B45]). Three parallel cultures were set up for each time point and treatment regimen, and all experiments were repeated at least twice.

To determine the contribution of growth factors, collagen Type I-OTCs were performed with and without integrated fibroblast (Schoop *et al.*, [@B39]). H-Smad7 cells were seeded on top, and the cultures were cultivated in plain medium or medium with TGFβ (2 ng/ml) supplemented or not with a neutralizing antibody against EGFR (2 μg/ml) throughout the entire cultivation time or a neutralizing antibody against KGF (2 μg/ml until day 9 and 1 μg/ml until day 21). The medium was renewed every second day.

To investigate the role of TGFβ, collagen Type I-OTCs were performed with HaCaT and H-Smad7 cells and treated with plain medium, TGFβ (2 ng/ml), TGFβ (2 ng/ml plus TGFβ-neutralizing antibody at 5 µg/ml), TGFβ-neutralizing antibody (5 μg/ml) only, and an irrelevant control antibody (5 μg/ml). The medium was renewed every other day, and the cultures were terminated at day 16.

For H-Smad7 antisense oligonucleotide experiments, the OTCs were prepared as described earlier in text and treated topically with 6 μM oligonucleotides (diluted in 100 μl of culture medium per OTC) by using either antisense Smad7 (1: TGA GGT AGA TCA TAG AAG) and (2: GCA CCA GTG TGA CC) or control oligonucleotides (1: ACT ACT ACA CTA GAC TAC) and (2: ACC GAC CGA CGT GT) (all designed, synthesized, and high-performance liquid chromatography--purified by Biognostik, Goettingen, Germany). The oligonucleotides were applied in medium on top of the epithelium every other day for 4 wk starting 24 h after plating the keratinocytes onto the dermal equivalent. In addition, untreated OTCs and OTCs topically treated only with medium were used as controls. Two series of experiments with three parallel cultures for each time point for two independent H-Smad7 clones were performed.

For the nuclear translocation assay, the cells were seeded on glass slides at a density of 5 × 10^5^ cells. After 24 h, TGF β1 at 5 ng/ml was applied for 90 min, and then the cells were fixed for further analysis.

Growth curves were performed by seeding 2 × 10^5^ cells in 6-cm culture dishes followed by cultivation for 48 h. Thereafter, the cells were counted every 24 h for 4 consecutive days using a CASY cell counter (Schärfe System, Reutlingen, Germany). TGFβ1 (5 ng/ml) was added 24 h after plating, and fresh TGFβ1 was added with each medium change every second day. Each time point and treatment was analyzed in duplicate, and one representative experiment of three repetitions is shown.

Histological analysis
---------------------

OTCs were fixed in 3.7% formaldehyde (in phosphate-buffered saline \[PBS\], pH 7.4) for 24 h, embedded in 3% agar (in PBS), and additionally fixed for 24 h. Thereafter, they were processed for routine histology following standard protocols. Five-micrometer sections were stained with hematoxylin and eosin, analyzed with an Olympus AX-70 microscope and recorded with a CCD camera (Color View, Olympus, Hamburg, Germany) applying Analysis Pro 6.0 software (Soft Imaging Systems, Muenster, Germany).

Detection of mucous substances
------------------------------

Alcian blue staining was performed on paraffin-embedded sections of OTCs after removal of paraffin and rehydration. The sections were acidified (3% acetic acid, 5 min), incubated in Alcian blue solution (1 g of Alcian blue, 3 ml of glacial acetic acid, 97 ml of distilled H~2~O, 30 min), and counterstained with Nuclear fast red (0.2 g of Nuclear fast red, 15 mM aluminum phosphate, 200 ml of H~2~O, 3 min). The sections were rinsed in water, dehydrated in graded ethanol solutions transferred into xylene, and then mounted in Eukitt.

For PAS staining, the sections were oxidized in Periodic acid (0.6%, 10 min) and stained with Schiff's reagent (5 g of basic Fuchsin in 135 ml of 1M HCl, 5 g of potassium disulfide in 200 ml of H~2~O, 5--10 min), followed by immersion in disulfide water and running tap water. Nuclei were counterstained with hematoxylin, differentiated in acidic ethanol solution (70% ethanol containing 2.5% HCl), dehydrated, and mounted.

The reagents for Accustain mucicarmine stain were obtained from Sigma-Aldrich (St. Louis, MO) and applied according to the manufacturer's instructions (procedure no. HT30).

Indirect immunofluorescence microscopy
--------------------------------------

OTCs were embedded in Tissue Tek (Sakura Finetek, Zoeterwoude, The Netherlands) and frozen in the gas phase of liquid nitrogen. Cryostat sections (5 μm) or cells grown on slides were fixed in 80% methanol at 4°C and 100% acetone at --20°C and air-dried. After rehydration in PBS and blocking with 5% (wt/vol) bovine serum albumin in PBS supplemented with 0.02% (wt/vol) sodium azide, specimens were treated with the respective primary antibodies for 2 h at room temperature. Generally, two primary antibodies of the respective species of the primary antibodies were combined on the same section. After washing in PBS, the sections were incubated with an appropriate combination of fluorochrome-conjugated secondary antibodies for 1 h at room temperature. The nuclei were counterstained with Hoechst dye 33258. Slides were rinsed in PBS and mounted in Permafluor. Images were recorded as described earlier in text.

Western blot analysis
---------------------

Western blot analyses were performed as described previously (Cerezo *et al.*, [@B4]). Cell pellets were lysed in RIPA buffer, protein concentrations determined by Bradford staining (Bio-Rad Laboratories, Munich, Germany), and 30 μg of total protein was separated by SDS--PAGE using a 12% polyacrylamide gel. For antibody detection, the SuperSignal West Pico chemiluminescence detection system (Pierce/Perbio Science, Bonn, Germany) was used. Ponceau-stained nitrocellulose membranes served as controls for loading and transfer efficiency.

Antibodies and reagents
-----------------------

Recombinant human TGFβ1 (R&D Systems, Wiesbaden, Germany) was dissolved in 4 mM HCl and diluted to a stock concentration of 2 μg/ml. Neutralizing antibodies were used for the EGFR (humanized mouse monoclonal anti-EGFR antibody, Cetuximab; Merck, Darmstadt, Germany), the KGF (mouse monoclonal anti-KGF/FGF-7 antibody), TGFβ (mouse monoclonal anti TGFβ1, -2, -3 antibody), and mouse monoclonal anti--pox virus-chemokine inhibitor (CCI) antibody was used as isotypic control antibody (all three from R&D Systems, Wiesbaden, Germany).

Primary antibodies for immunoblotting were as follows: rabbit polyclonal antibodies against phospho-Smad2 (Persson *et al.*, [@B35]), phospho-Smad3 (Cell Signaling Technology/New England Biolabs, Frankfurt, Germany), cyclin D1 (ab31450; Abcam, Cambridge, UK), p15 (C-20), p21(C-19), and CDK4 (H-22), the mouse monoclonal antibodies against PAI-1 (C-9) as well as the goat polyclonal antibodies against Smad2/3 (N-19) and Smad7 (N-19) (all obtained from Santa Cruz Biotechnology, Heidelberg, Germany).

Primary antibodies for indirect immunofluorescence were as follows: rabbit polyclonal antibodies against Ki67 (Abcam), loricrin (provided by D. Hohl, CHUV, Lausanne, Switzerland), collagen Type IV (Heyl, Berlin, Germany), collagen I (US Biological, Swampscott, MA), vitronectin (Biomol, Hamburg, Germany), and Dsg2 (Progen, Heidelberg, Germany); mouse monoclonal antibodies against keratins K1/K10 (clone 8.60), E-cadherin (clone 5H9), and keratin K19 (clone Ks19.1); Dsg1/2 (clone DG3/10), Dsg1 (clone P124), and Dsg3 (G194) (all obtained from Progen, Heidelberg, Germany); involucrin (clone SY5) and keratin K4 (clone 6B10) (both obtained from Sigma, Taufkirchen, Germany); transglutaminase-1 and filaggrin (both obtained from Cell Systems, St. Katharinen, Germany); filaggrin (cone FLG01; Thermo Fisher Scientific, Fremont, CA) and keratin K7 (GE Healthcare, formerly Amersham, Munich, Germany); rat monoclonal antibodies against integrin α6 and β1 (both obtained from Millipore, formerly Chemicon, Schwalbach, Germany); and guinea pig polyclonal antibodies against keratins K13, K2, K5, K14, cingulin, vimentin, and Dsg4 (all obtained from Progen).

The secondary antibodies used for immunoblotting were peroxidase-conjugated donkey anti--mouse-, anti--rabbit-, and anti--goat immunoglobulin (Ig)G (H+L) (all obtained from Dianova, Hamburg, Germany) and, for immunofluorescence, goat anti--mouse and anti--rabbit IgG (H+L) Alexa Fluor 488 (both obtained from Mole­cular Probes/Invitrogen, Karlsruhe, Germany), donkey anti--mouse-, anti--rabbit-, anti--goat-, and anti--guinea pig IgG (H+L) Cy3 (Dianova). Nuclei were counterstained with Hoechst dye 33258 (Sigma, Taufkirchen, Germany).

In situ hybridization
---------------------

For in situ hybridization, a 371 bp cDNA probe of the Smad7 coding 5′- end (nt pos. 40--410) was generated by PCR and cloned into pCR2.1 vector. This system allows the synthesis of a specific probe by using T7-RNA polymerase (Roche). As a positive control, a specific probe of the keratin K14 3′-coding region of 380 bp was used.

Labeling of the cRNA probes and the in situ hybridization procedure were performed essentially as described (Langbein *et al.*, [@B25]). Briefly, for the Dig-labeling of the cRNA probe, the DIG-RNA labeling Kit (Roche) was used following the instructions of the manufacturer. After denaturation of the sections at 90°C, prehybridization with 2× saline-sodium citrate/50% formamide and hybridization with the probe was done at 42°C overnight. Stringent washing steps were done at 50°C including one RNaseA digestion step. For detection, the bound probe was labeled with an alkaline phosphatase--labeled goat anti-Dig antibody (1:300 vol; Roche). For blocking internal tissue phosphatases, sections were treated with levamisole (2 mg/10 ml) for 30 min. For the color substrate reaction of the phosphatase, Nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate substrate tablets (Roche) were used. Positive (K14) and negative (hybridization buffer; sense probes) controls were performed.

RNA isolation, RT-PCR, and quantitative RT-PCR analysis
-------------------------------------------------------

Total RNA was isolated from the epithelia (OTCs) separated from the dermal equivalent. RNA was extracted using RNeasy according to the manufacturer's instructions (Qiagen). One microgram of total RNA was reversely transcribed to cDNA (Omniscript; Qiagen) as described previously (Cerezo *et al.*, [@B5]). The cDNA template was used in a PCR with the primers for IKKα: forward primer 1603--1622, AAAGGCCATCCACTATGCTG, and reverse primer 1874--1855, GACCAAACAGCTCCTTGAGC, with a PCR product length of 272 base pairs; for Klf4, forward primer 1387--1406, CGCTCCATTACCAAGAGCTC, and reverse primer 1726--1707, ATGTGTAAGGCGAGGTGGTC, with a PCR product length of 340 base pairs. For mucin 4: forward primer CTT CAC CTC CCC ACT CTT CA, and reverse primer TGT AGC CCC CGT TGT TTG T, mucin 13: forward primer ATA ATC ACC GCT TCA TCT CCA, and reverse primer GTC ATC AGC ACG CAT TTC A, and Gcnt3: forward primer TTC AAA GAG GCG GTC AAA GCA, and reverse primer TGT CGT ACT TGG GGT GGT TGG. PCR conditions for 25 cycles for Klf4, 30 cycles for IKKα, 23 cycles for GAPDH, and 30 cycles for mucin 4, mucin 13, and Gcnt3 were as follows: denaturation for 2 min at 95°C, 15 s at 94°C, 30 s at 60°C, 30 s at 72°C, and final extension for 10 min at 72°C.

Quantitative RT-PCR (qRT-PCR) was performed in a capillary-based LightCycler 1.2 according to the manufacturer's instructions. Each reaction consists of a 15-μl mix in nuclease-free water containing 4 μl of LightCyclerTaqMan master, 0.2 μM Smad3 forward (GTCTGCAAGATCCCACCAG) and reverse (AGCCCTGGTTGACCGACT) primers, and 0.1 μM UPL-probe \#79 (Universal ProbeLibrary; Roche). This mix was then pipetted into the capillaries, and 50--200 ng of cDNA in 5 μl of RNase-free water was added. A negative control containing water instead of cDNA was run for each primer pair and reaction. After a preincubation at 95°C for 10 min, the amplification was carried out in 45 cycles, each consisting of heating for 10 s at 95°C and annealing for 30 s at 60°C. Fluorescence was measured at 530 nm after each cycle and monitored by LightCycler software (version 3.5). The reaction was finished with a cooling step at 40°C for 10 s. For relative quantification, the gene of interest and a housekeeping gene (e.g., GAPDH) were analyzed for each control and sample. Using the software and the algorithm Second Derivative Maximum, the crossing point of each gene in a given sample was calculated identifying the cycle number at which the fluorescence signal rises above background fluorescence. With these crossing point values, the ratio of relative mRNA expression of control versus sample normalized to the housekeeping gene was calculated. Controls were always set to 1. To verify the quality of the primer/probe combination and the efficiency of the PCR, standard curves were performed for each test.
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BM

:   basement membrane

Dsg

:   desmoglein

ECM

:   extracellular matrix

EGFR

:   epidermal growth factor receptor

EMT

:   epithelial--mesenchymal transition

Gcnt3

:   glucosaminyl (N-acetyl) transferase 3, mucin type

IFE

:   interfollicular epidermis

IKKα, inhibitor of nuclear factor kappa-B kinase subunit α

KGF

:   keratinocyte growth factor

Klf4

:   Krueppel-like factor 4

OTC

:   organotypic culture

PAS

:   Periodic acid--Schiff

TGFβ

:   transforming growth factor-β
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